(Q43663302)

25 November 2017

title

Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares (English)

1 reference

25 November 2017

1 reference

1 reference

A Matrat

1

1 reference

25 November 2017

C Veysseyre-Balter

2

1 reference

25 November 2017

P Trolliet

3

1 reference

25 November 2017

E Villar

4

1 reference

25 November 2017

F Dijoud

5

1 reference

25 November 2017

J Bienvenu

6

1 reference

25 November 2017

N Fabien

7

1 reference

25 November 2017

language of work or name

1 reference

13 October 2010

1 reference

25 November 2017

1 reference

25 November 2017

volume

20

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

28-34

1 reference

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long-term observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

Lupus nephritis: the central role of nucleosomes revealed

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379871

21 January 2018

Identifiers

DOI

10.1177/0961203310379871

1 reference

25 November 2017

1 reference